Bismuth‐containing quadruple therapy is an effective alternative first‐line therapy for Helicobacter pylori infection. We evaluated the efficacy and safety of a modified twice‐a‐day bismuth quadruple regimen (BQT‐2) with low‐dose (1000… Click to show full abstract
Bismuth‐containing quadruple therapy is an effective alternative first‐line therapy for Helicobacter pylori infection. We evaluated the efficacy and safety of a modified twice‐a‐day bismuth quadruple regimen (BQT‐2) with low‐dose (1000 mg total) metronidazole as first‐line therapy for the eradication of H pylori.
               
Click one of the above tabs to view related content.